MRVINasdaqPharmaceutical PreparationsFiscal year ends December 31

MARAVAI LIFESCIENCES HOLDINGS, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$6.99+0.20 (+2.95%)

Close on Oct 19, 2026

Market cap: $1.03B
P/E (TTM): –
Dividend yield: –

MARAVAI LIFESCIENCES HOLDINGS, INC. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q3 2022 2022-09-30	Q2 2022 2022-06-30	Q1 2022 2022-03-31	Q4 2021 2021-12-31	Q3 2021 2021-09-30	Q2 2021 2021-06-30	Q1 2021 2021-03-31	Q4 2020 2020-12-31	Q3 2020 2020-09-30	Q2 2020 2020-06-30	Q1 2020 2020-03-31	Q4 2019 2019-12-31	Q4 2018 2018-12-31
Cash & Equivalents	70	166	217	244	270	285	322	578	573	562	575	580	580	628	632	617	551	431	551	548	375	248	236	125	84	77	25	22
Cash & Short-Term Investments	70	166	217	244	270	285	322	578	573	562	575	580	580	628	632	617	551	431	551	548	375	248	236	125	84	77	25	22
Receivables	31	33	25	23	28	28	39	29	35	37	55	46	49	56	139	114	120	120	118	66	84	122	51	–	–	–	–	–
Inventory	41	40	40	45	47	50	50	51	49	50	51	49	47	55	43	62	60	51	52	56	48	47	33	–	–	–	–	–
Prepaid Expenses & Other	13	12	13	14	15	13	18	22	17	17	19	23	23	26	26	23	20	16	20	17	13	8.92	11	–	–	–	–	–
Total Current Assets	156	252	296	326	360	376	429	679	682	668	700	701	699	766	848	836	759	619	740	687	644	426	332	–	–	–	–	–
Property, Plant & Equipment	142	147	151	159	163	166	164	165	166	162	163	154	142	88	53	48	47	48	46	108	105	105	101	–	–	–	–	–
Accumulated Depreciation	–	–	-68	–	–	–	-53	–	–	–	-32	–	–	–	-20	–	–	–	-13	–	–	–	-11	–	–	–	–	–
Operating Lease Right-of-Use Assets	–	–	39	–	–	–	53	–	–	–	60	63	65	67	64	54	47	–	49	–	–	–	–	–	–	–	–	–
Goodwill	129	129	129	129	129	160	160	172	326	326	326	326	326	327	284	284	284	284	153	153	153	224	224	–	–	–	–	–
Intangible Assets	138	145	152	186	193	200	195	202	207	214	221	228	235	242	217	223	229	235	118	121	125	173	178	–	–	–	–	–
Deferred Tax Assets	–	–	–	–	–	–	–	–	–	–	0	774	770	767	766	771	780	793	808	821	570	420	432	–	–	–	–	–
Other Long-Term Assets	38	40	42	49	52	58	60	61	63	75	78	86	93	127	116	87	72	64	53	4.11	4.03	4.30	4.16	–	–	–	–	–
Total Assets	604	713	771	849	897	960	1,008	1,278	1,444	1,445	1,487	2,268	2,264	2,315	2,282	2,249	2,172	2,043	1,918	1,895	1,601	1,352	1,271	–	–	–	–	–
Accounts Payable	7.13	8.54	2.91	8.00	12	9.53	12	–	–	–	–	–	–	4.78	5.99	9.46	23	10	8.15	8.92	12	9.81	8.17	–	–	–	–	–
Accrued Expenses	30	29	37	48	50	45	40	39	41	35	60	56	50	70	53	60	44	32	35	31	25	29	39	–	–	–	–	–
Current Portion of Long-Term Debt	1.13	5.44	5.44	5.44	5.44	5.44	5.44	5.44	5.44	5.44	5.44	5.44	5.44	5.44	5.44	5.44	5.44	5.44	6.00	6.00	6.00	6.00	6.00	–	–	–	–	–
Current Debt	1.13	5.44	5.44	5.44	5.44	5.44	5.44	5.44	5.44	5.44	5.44	5.44	5.44	5.44	5.44	5.44	5.44	5.44	6.00	6.00	6.00	6.00	6.00	–	–	–	–	–
Current Portion of Leases	–	–	7.80	8.14	7.93	–	7.48	7.28	7.12	6.97	6.78	7.09	6.92	6.75	6.27	5.83	4.31	–	3.72	–	–	–	0	–	–	–	–	–
Current Income Taxes Payable	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	–	–	–	0.10	–	1.45	–	2.29	–	–	–	–	–
Deferred Revenue (Current)	–	–	1.99	1.73	1.64	2.76	2.38	1.90	2.15	2.21	3.36	2.55	2.46	2.05	3.09	5.82	5.44	3.69	10	67	109	119	78	–	–	–	–	–
Total Current Liabilities	38	43	45	62	70	63	57	64	69	59	87	78	75	125	110	116	113	87	94	114	165	165	131	–	–	–	–	–
Long-Term Debt	146	236	286	287	288	289	290	516	517	518	519	520	520	521	522	523	524	524	525	526	527	528	529	–	–	–	–	–
Long-Term Leases	–	–	34	36	38	–	41	–	–	–	48	50	52	54	52	44	–	–	41	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	–	–	42	44	46	–	49	7.28	7.12	6.97	54	57	59	60	58	50	4.31	–	45	–	–	–	0	–	–	–	–	–
Deferred Tax Liabilities	–	–	–	–	2.03	1.97	0.01	–	–	–	–	6.69	8.51	8.68	0	–	–	–	0	0	0	8.57	8.61	–	–	–	–	–
Other Long-Term Liabilities	34	36	36	38	38	44	52	54	54	59	59	65	63	66	69	58	51	67	41	1.55	1.06	2.31	2.23	–	–	–	–	–
Total Liabilities	248	344	398	417	429	429	431	666	671	667	698	1,375	1,367	1,415	1,377	1,407	1,398	1,389	1,373	1,441	1,268	1,142	1,116	–	–	–	–	–
Total Debt	147	241	292	293	294	295	296	522	523	523	524	525	526	527	527	528	529	530	531	532	533	534	535	–	–	–	–	–
Additional Paid-In Capital	208	202	199	197	191	187	182	176	168	134	129	125	120	114	138	134	131	129	128	173	118	86	85	–	–	–	–	–
Retained Earnings	-6.03	6.39	10	46	71	111	141	167	264	274	286	392	398	405	405	367	323	251	185	129	75	26	0.85	–	–	–	–	–
Comprehensive Income & Other	0.46	0.47	0.52	0.58	0.57	0.32	0	–	–	–	–	–	–	–	–	–	–	–	0	0	-0.04	-0.04	-0.04	–	–	–	–	–
Shareholders' Equity	205	212	212	245	266	301	325	345	435	411	417	519	521	522	545	504	457	383	315	303	194	113	89	–	–	–	–	–
Noncontrolling Interest	151	158	160	186	202	230	252	268	338	367	373	373	377	379	360	338	317	272	230	153	142	100	66	–	–	–	–	–
Total Equity	356	369	373	432	468	530	577	613	772	777	790	892	898	901	905	842	774	654	545	457	337	214	155	–	–	–	145	–
Total Liabilities & Equity	604	713	771	849	897	960	1,008	1,278	1,444	1,445	1,487	2,268	2,264	2,315	2,282	2,249	2,172	2,043	1,918	1,895	1,601	1,352	1,271	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 34.9%
Operating margin: -56.1%
Net margin: -37.1%
Return on equity, FY2025: -48.6%

Financial strength

Current ratio: 4.05
Debt to equity: 0.72
Debt to assets: 24.4%
Cash to current liabilities: 182.4%

Valuation

P/E ratio: –
Price to sales: 4.96
Price to book: 5.06
Dividend yield: –